$10.62
0.767.71%
Últ. Act.: Oct 22, 7:23 AM
$10.41
0.555.58%
MiNK Therapeutics (INKT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.60 | $-0.77 | $-0.68 | $-0.86 |
| Actual | $-0.62 | $-0.57 | $-0.56 | $-0.65 |
| Surprise | -3.33% | +26.0% | +17.6% | +24.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.35 | $-0.39 |
| Revenue | ||
| Consensus | $1.6M | $1.8M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.62 | $-0.60 | -3.33 % |
| Q1 | May 15, 2026 | $-0.57 | $-0.77 | 26.0 % |
| Q4 | Mar 31, 2026 | $-0.56 | $-0.68 | 17.6 % |
| Q3 | Nov 14, 2025 | $-0.65 | $-0.86 | 24.4 % |